Industry

IPH6401/SAR’514 is a BCMA-targeting NK cell engager using Sanofi’s proprietary CROSSODILE® multi-functional platform. It was developed jointly and benefits from the dual NK targeting of Innate’s ANKETTM proprietary platform Selection of IPH6401/SAR’514 triggers a €3M milestone payment to Innate MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) … [Read more…]

– Peking Union Medical College Hospital Primary Clinical Trial Site BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc. (HKEX:1228), a China and US-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announced that the first patient has been dosed in the CAN103 Phase 1/2 trial in … [Read more…]

BEIJING, China & TOKYO–(BUSINESS WIRE)–#CCR8–February 1st 2021, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) entered a strategic collaboration with LiberoThera Co., Ltd (“LiberoThera”) to co-develop fully human GPCR antibodies using Biocytogen’s advanced antibody discovery platform based on fully human antibody RenMabTM mice combined with LiberoThera’s outstanding membrane antigen preparation technology. In around a year since the … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–#monkeypox–With the World Health Organization set to meet for the second time tomorrow to decide whether to declare monkeypox a Public Health Emergency of International Concern (PHEIC), AIDS Healthcare Foundation strongly urges the WHO to acknowledge the rapid, uncontrolled spread of the virus and declare it a pandemic. Monkeypox has spread to over … [Read more…]

OAKLAND, Calif.–(BUSINESS WIRE)–#CWCI–Proposals to cut the amount of time California workers’ compensation claims administrators have to investigate work-related injuries and determine employer liability may be easier said than done given existing statutory and regulatory time frames for the various steps within the process, many of which claims organizations do not control, according to a new … [Read more…]

BOULDER, Colo.–(BUSINESS WIRE)–$CLVS–First paragraph, second sentence of release should read: Clovis’ senior management will host a conference call and live audio webcast at 8:30am ET to discuss Clovis’ results and business outlook in greater detail. (instead of Clovis’ senior management will host a conference call and live audio webcast at 6:30am ET to discuss Clovis’ … [Read more…]

The Glioblastoma Foundation Launches Several Initiatives in Support of its National Commitment to Ensuring Accessible, Individualized Patient Care and Treatment DURHAM, N.C.–(BUSINESS WIRE)–Glioblastoma Awareness Day observed today, July 20, 2022, aims to increase public awareness of glioblastoma and honor those who have lost their lives to the devastating disease. In conjunction with the observance, the … [Read more…]

DALLAS & NEW YORK–(BUSINESS WIRE)–Signify Health, Inc. (NYSE: SGFY), a leading value-based healthcare platform enabled by advanced analytics, technology and nationwide healthcare networks, announced that it will release its financial results for the second quarter 2022 after the market closes on Wednesday, August 3, 2022, and will hold a conference call at 8:30am ET on … [Read more…]

EXETER, N.H.–(BUSINESS WIRE)–Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products which are used to treat patients of all ages suffering from respiratory distress, today announced that it will release financial results for the second quarter of … [Read more…]

KGK to conduct Phase II clinical trial to test the efficacy of psilocybin on treatment resistant PTSD VANCOUVER, British Columbia–(BUSINESS WIRE)–$KONEF #ketamine–Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital … [Read more…]